Which makes me question how the whole Nanose and Akida connection was managed. The communication around this has been very poor from the the company. I do not buy the “it’s difficult with the ASX” thing. Many companies put out project updates, or scientific update notices through the ASX. This should have been an offical ASX announcement and it would have given the company more traction and recognition.
An update is required on FDA or other regulatory body approval timelines for this. Even an update to say a filing for approval has occurred. Maybe a reason for LDN’s removal?
As always this is totally my opinion.
Which makes me question how the whole Nanose and Akida...
-
- There are more pages in this discussion • 1,042 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $399.0M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.0¢ | 21.0¢ | $990.6K | 4.606M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 177633 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 517381 | 15 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |